Report: Younger women battling breast cancer face more aggressive diagnoses

May 3, 2017

As the nation struggles with soaring health care costs, a new report by RTI International shows that younger women diagnosed with breast cancer face a significant treatment burden.

The report, published in Breast Cancer Research and Treatment, estimates the cost of breast cancer among women 45 years and younger.

"Younger women diagnosed with breast cancer often face more aggressive treatment, and are therefore more vulnerable to financial hardships," said Benjamin T. Allaire, report author and research economist at RTI. "This hardship leads some to forgo or delay necessary treatments, which may lead to immediate or future complications."

Analyzing data from the North Carolina Central Cancer Registry, report authors found that with private health insurance cost substantially more to treat than . Excess costs among women under the age of 45 enrolled in the registry for a year totaled $97,000, while older women had excess costs of $76,000. Younger women are more likely to be diagnosed with later stage cancers (Stages III and IV), and when they are, the excess costs to treat them are more than $132,000, compared to $124,000 for older women.

"Based on previous research, we knew that younger women cost more to treat than older women, but did not fully understand why," Allaire said. "Our new research reveals that it is because they are diagnosed with later stage cancers and they require more intense treatment. The magnitude of these costs underscores the importance of maintaining insurance coverage."

The report concludes that more research is needed to explore the drivers of cost differences and the impact of higher costs on the quality of life for younger survivors.

Explore further: Different breast cancer treatment options vary widely in their cost-effectiveness

Related Stories

Different breast cancer treatment options vary widely in their cost-effectiveness

April 10, 2017
A new study published today in the Journal of the National Cancer Institute indicates that different therapies for early-stage breast cancer have very different relative values. Some therapies may have fewer complications ...

Younger breast cancer survivors face bigger hurdles

February 1, 2016
Breast cancer takes a daunting toll on all women, but it hits younger women especially hard, finds a new study from the Brown School at Washington University in St. Louis.

Researchers identify breast cancer risk factors for younger, black women

October 19, 2016
Black women under the age of 45 are at increased risk for an aggressive form of breast cancer [estrogen receptor (ER) negative] if they experienced a high number of pregnancies, never breast fed, and/or had higher waist-to-hip ...

Older women may not be offered breast reconstruction after mastectomy

February 8, 2017
A national study from England indicates that older women are often not offered immediate breast reconstruction following a mastectomy, even though guidelines state that surgeons should discuss reconstruction with all suitable ...

Racial differences in male breast cancer outcomes

May 4, 2015
While black and white men under age 65 diagnosed with early-stage breast cancer received similar treatment, blacks had a 76% higher risk of death than whites, according to a new study. The study, published in the Journal ...

Mastectomy and reconstruction has higher complication rates, costs than lumpectomy and radiation

December 10, 2015
Among the various guideline-concordant local therapy options available for women with early-stage breast cancer in the United States, mastectomy plus reconstruction had the highest complication rates and complication-related ...

Recommended for you

Drug suppresses spread of breast cancer caused by stem-like cells

December 12, 2017
Rare stem-like tumor cells play a critical role in the spread of breast cancer, but a vulnerability in the pathway that powers them offers a strategy to target these cells using existing drugs before metastatic disease occurs, ...

MRI scans predict patients' ability to fight the spread of cancer

December 12, 2017
A simple, non-invasive procedure that can indicate how long patients with cancer that has spread to the brain might survive and whether they are likely to respond to immunotherapy has been developed by researchers in Liverpool.

Insights on how SHARPIN promotes cancer progression

December 11, 2017
Researchers at Sanford Burnham Prebys Medical Discovery (SBP) and the Technion in Israel have found a new role for the SHARPIN protein. In addition to being one of three proteins in the linear ubiquitin chain assembly complex ...

Glioblastoma survival mechanism reveals new therapeutic target

December 11, 2017
A Northwestern Medicine study, published in the journal Cancer Cell, has provided new insights into a mechanism of tumor survival in glioblastoma and demonstrated that inhibiting the process could enhance the effects of radiation ...

A new weapon against bone metastasis? Team develops antibody to fight cancer

December 11, 2017
In the ongoing battle between cancer and modern medicine, some therapeutic agents, while effective, can bring undesirable or even dangerous side effects. "Chemo saves lives and improves survival, but it could work much better ...

Liver cancer: Lipid synthesis promotes tumor formation

December 11, 2017
Lipids comprise an optimal energy source and an important cell component. Researchers from the Biozentrum of the University of Basel and from the University of Geneva have now discovered that the protein mTOR stimulates the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.